comparemela.com

Latest Breaking News On - Shulamit levenberg - Page 2 : comparemela.com

Technion scientists harness ultrasound for drug delivery and tissue implantation

Technion scientists harness ultrasound for drug delivery and tissue implantation
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Tel avivShulamit levenbergLior debbiMajd machourTechnion facultyBiomedical engineering

Technion Scientists Harness Ultrasound for Drug Delivery and Tissue Implantation

Israeli scientists from the Technion in Haifa have found a way to harness ultrasounds for drug delivery and tissue implantation. The researchers were led by Prof. Shulamit Levenberg and they developed an “innovative non-invasive method” for bio-printing live cells and tissues deep within the body using external sound wave irradiation. You have probably heard about […]

Shulamit levenbergJewish business newsUnlikex rays

Technion breakthrough for better drug delivery and tissue implantation

Researchers develop ultrasound for non-invasive method for bio-printing live cells and tissues deep within the body.

Majd machourShulamith levenbergLior debbiShulamit levenbergIsrael institute of technologyTechnion israel instituteSmall methods

Scientists harness ultrasound for drug delivery and tissue implantation

Scientists harness ultrasound for drug delivery and tissue implantation
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Lior debbiShulamit levenbergMajd machourSmall methodsTechnion facultyUltrasound mediated polymerizationCell deliveryDrug delivery

NurExone s Intellectual Property Portfolio Expands

Innovations and know-how in exosome production suited for many clinical applicationsTORONTO and HAIFA, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, proudly underscores its expanding Intellectual Property (IP) portfolio, which will serve as the foundation for its strategic goal of licensing the innovative ExoTherapy platform to interested biotech companies. NurExone’s Intellectual

Shulamit levenbergLior shaltielEva reuterTechnion centerNurexone biologic incNational phasesCompany or nurexoneVenture exchangeTechnion israel institute of technologyThesis capital incRegulation services providerExone biologicIntellectual propertyExtracellular vesiclesIsrael instituteChief scientific advisor

vimarsana © 2020. All Rights Reserved.